RMD - ResMed Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
99.90
+0.13 (+0.13%)
As of 1:07PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close 99.77
Open 99.83
Bid 99.87 x 800
Ask 99.90 x 1000
Day's Range 99.51 - 100.28
52 Week Range 90.64 - 118.50
Volume 352,939
Avg. Volume 1,194,500
Market Cap 14.316B
Beta (3Y Monthly) 0.47
PE Ratio (TTM) 32.03
EPS (TTM) 3.12
Earnings Date Apr 24, 2019 - Apr 29, 2019
Forward Dividend & Yield 1.48 (1.48%)
Ex-Dividend Date 2019-02-06
1y Target Est 106.43
Trade prices are not sourced from all markets
  • 84% of people with asthma may be using their inhalers incorrectly, Propeller Health study finds
    PR Newswire 4 hours ago

    84% of people with asthma may be using their inhalers incorrectly, Propeller Health study finds

    MADISON, Wis., Feb. 21, 2019 /PRNewswire/ -- The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology: In practice by digital therapeutics company Propeller Health, in partnership with the University of Colorado School of Medicine and Children's Hospital Colorado. Many asthma medicines require that patients take two "puffs" of their inhaler to receive the prescribed dose.

  • Reuters 17 hours ago

    Fisher & Paykel, ResMed settle global patent disputes; shares jump

    New Zealand medical device maker Fisher & Paykel Healthcare Corp Ltd and U.S. rival ResMed Inc have agreed to settle patent infringement disputes, ending a three-year tussle that spanned the globe and cost each side millions of dollars in legal fees. In a joint statement on Thursday, the companies agreed to end all ongoing infringement cases and said neither would admit liability or make any payment. Fisher & Paykel shares were 6.9 percent higher after the announcement, reaching a more than four-month peak, whereas ResMed's Australian depository receipts were 1.1 percent firmer.

  • Reuters 22 hours ago

    NZ's Fisher & Paykel and ResMed settle global patent disputes

    Medical device maker Fisher & Paykel Healthcare and U.S.-based ResMed on Thursday agreed to settle disputes over patent infringement, bringing to an end a tussle spanning the globe. The two companies had ...

  • ResMed and Fisher & Paykel Healthcare Announce Settlement of Global Patent Infringement Litigation
    Business Wire yesterday

    ResMed and Fisher & Paykel Healthcare Announce Settlement of Global Patent Infringement Litigation

    ResMed (NYSE: RMD, ASX: RMD), and Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today announced an agreement to settle all outstanding patent infringement disputes between the companies in all venues around the world. The settlement involves no payment or admission of liability by either side. “I am pleased we were able to resolve these disputes,” said ResMed CEO Mick Farrell.

  • Will ResMed Inc.’s (NYSE:RMD) Earnings Grow In The Year Ahead?
    Simply Wall St. 8 days ago

    Will ResMed Inc.’s (NYSE:RMD) Earnings Grow In The Year Ahead?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! As ResMed Inc. (NYSE:RMD) released its earningsRead More...

  • Markit 13 days ago

    See what the IHS Markit Score report has to say about ResMed Inc.

    ResMed Inc NYSE:RMDView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for RMD with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding RMD totaled $11.33 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • GlobeNewswire 21 days ago

    A New Era in Healthcare with Digital Health: Innovest Global Inc. (OTC: IVST), eWellness Healthcare, ResMed Inc. and Progressive Care Inc.

    Investorideas.com, a leading investor news resource covering technology and healthcare stocks releases a snapshot looking at how healthcare is changing in the digital age. Investorideas recently reported on how Digital Health technologies enabling out-of-hospital care and monitoring are forecast to grow by 30 percent and cross the $25 billion mark. In the article, Kamaljit Behera, Industry Analyst, Transformational Health, said, "In this highly digitized environment, artificial intelligence (AI) will permeate the life sciences ecosystem, and its use in healthcare IT (HIT) is likely to cross $1.7 billion by the end of 2019.

  • ResMed (RMD) Q2 2019 Earnings Conference Call Transcript
    Motley Fool 27 days ago

    ResMed (RMD) Q2 2019 Earnings Conference Call Transcript

    RMD earnings call for the period ending December 31, 2018.

  • Barrons.com 27 days ago

    The Dow Rises 184 Points Because the Fed Trumps the End of the Shutdown

    The Dow Jones Industrial Average rose 0.8% to close at 24,737.20 on a report that the Fed might stop winding down its bond holdings earlier than expected.

  • GuruFocus.com 27 days ago

    3 Stocks Move Friday

    ResMed, Intuitive Surgical fall, OSI Systems rises

  • Associated Press 27 days ago

    Western Digital, Starbucks rise while AbbVie, Intel drop

    Stocks that moved substantially or traded heavily Friday: Western Digital Corp., up $3.02 to $43.16 The hard-drive maker reported better-than-expected quarterly financial results and an upbeat forecast. ...

  • TheStreet.com 27 days ago

    ResMed Tanks on Second-Quarter Revenue Miss

    The San Diego company reported a 9% increase in adjusted revenue to $651.1 million but lagged Wall Street's expectations of $667 million. "We had a solid quarter with top-line growth and gross margin expansion, as well as continued fiscal discipline to drive leverage and improved operating profit," said Mick Farrell, ResMed's CEO. Through the first half of the company's fiscal year, ResMed has posted an increase of 11% on adjusted revenue while earnings have gained 9%.

  • Acquisitions Cause ResMed's Profit Growth to Stall
    Motley Fool 27 days ago

    Acquisitions Cause ResMed's Profit Growth to Stall

    Lavish spending on additions to the company's growing software business took a toll on net income.

  • Why ResMed Is Plunging Today
    Motley Fool 27 days ago

    Why ResMed Is Plunging Today

    Disappointing quarterly results took a toll on the medical-device stock.

  • CNBC 27 days ago

    Stocks making moves midday: Airlines, Ford, Western Digital, Vale & more

    These are the companies making headlines in the middle of Friday trading:Intel INTC , AMD AMD – Intel fell 5.5 percent after the chipmaker said it expects revenue to be nearly flat compared to last year.

  • ResMed Earnings: RMD Stock Plunges on Q2 Revenue Miss
    InvestorPlace 27 days ago

    ResMed Earnings: RMD Stock Plunges on Q2 Revenue Miss

    The ResMed earnings report for its fiscal second quarter of 2019 has RMD stock taking a dive on Friday. Source: Shutterstock ResMed (NYSE:RMD) reported revenue of $651.10 million for its fiscal second quarter of 2019. This is an increase over its revenue of $601.27 million for its fiscal second quarter of 2018. However, it was a real blow to RMD stock by missing Wall Street's revenue estimate of $672.91 million for the period. While ResMed notes that its revenue saw a strong 9% boost in the U.S., Canada and Latin America, it wasn't as strong in other areas. This includes its Europe and Asia markets, where revenue only saw a combined growth of 1%. InvestorPlace - Stock Market News, Stock Advice & Trading Tips The most recent ResMed earnings report also saw it bring in earnings per share of $1.00. This matches the company's earnings per share from the same period of the year prior. It also has the company beating out analysts' earnings per share estimate of 95 cents for the quarter, but that wasn't enough to keep RMD stock from falling today. ResMed earnings for its fiscal second quarter of the year also includes net income of $124.64 million. The medical equipment company reported net income of $9.53 million in its fiscal second quarter of the previous year. * 5 Best Stocks to Buy and Hold for the Long Term Operating income reported in the ResMed earnings for its fiscal second quarter of 2019 was $157.08 million. This is up from the company's operating income of $146.02 million reported during the same time last year. RMD stock was down 17% as of noon Friday. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Semiconductor Stocks to Buy Now * 10 of the Best Stocks to Invest In for February * 5 Top Stocks for a FOMO Rally As of this writing, William White did not hold a position in any of the aforementioned securities. Compare Brokers The post ResMed Earnings: RMD Stock Plunges on Q2 Revenue Miss appeared first on InvestorPlace.

  • ResMed (RMD) Q2 Earnings in Line, Revenues Miss Estimates
    Zacks 27 days ago

    ResMed (RMD) Q2 Earnings in Line, Revenues Miss Estimates

    ResMed (RMD) benefits from growth at CER across all geographies. However, device sales in France and Japan get affected.

  • Dow Jones Futures Pare Gains On Mueller Probe Arrest; Intel Leads 5 Top Stocks Moving
    Investor's Business Daily 27 days ago

    Dow Jones Futures Pare Gains On Mueller Probe Arrest; Intel Leads 5 Top Stocks Moving

    Stone futures rose but pared gains on news that Trump adviser Roger Stone had been arrested. Intel fell on guidance. Starbucks rose on strong earnings.

  • Highly Rated Medtech Stock Topples On Mixed Earnings Report
    Investor's Business Daily 28 days ago

    Highly Rated Medtech Stock Topples On Mixed Earnings Report

    ResMed stock crashed Thursday after the medical technology firm missed quarterly sales projections by $16 million. ResMed stock closed up a fraction.

  • Associated Press 28 days ago

    ResMed: Fiscal 2Q Earnings Snapshot

    On a per-share basis, the San Diego-based company said it had net income of 86 cents. Earnings, adjusted for amortization costs and costs related to mergers and acquisitions, came to $1 per share. The ...

  • Business Wire 28 days ago

    ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2019

    SAN DIEGO-- -- Year-over-year growth in revenue, gross margin, and operating profit Well-positioned for future growth through further penetration of untreated sleep apnea and expanding portfolio in respiratory care and Software as a Service Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. EST today at http://investor.resmed.com ResMed Inc. , a world-leading connected health ...

  • Is ResMed Inc. (NYSE:RMD) A High Quality Stock To Own?
    Simply Wall St. 28 days ago

    Is ResMed Inc. (NYSE:RMD) A High Quality Stock To Own?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...

  • Alphabet ECG Feature OK'd by FDA, Healthcare Plans on Track
    Zacks 29 days ago

    Alphabet ECG Feature OK'd by FDA, Healthcare Plans on Track

    Alphabet's (GOOGL) Verily scores FDA clearance for its electrocardiogram technology (ECG) in its Study Watch.

  • ISRG, RMD Earnings on Jan 24: Here Are the Key Predictions
    Zacks 29 days ago

    ISRG, RMD Earnings on Jan 24: Here Are the Key Predictions

    Let's take a look at the factors that are likely to influence the earnings results of a few MedTech bigwigs within the broader Medical space.

  • GuruFocus.com last month

    5 Companies Hit 52-Week Highs

    As of late, multiple companies have managed to reach yearly highs